Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine

Indrani Poddar, Patrick Michael Callahan, Caterina M. Hernandez, Xiangkun Yang, Michael G. Bartlett, Alvin V. Terry

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


While impairments of cognition in schizophrenia have the greatest impact on long-term functional outcome, the currently prescribed treatments, antipsychotic drugs (APDs), do not effectively improve cognition. Moreover, while more than 20 years have been devoted to the development of new drugs to treat cognitive deficits in schizophrenia, none have been approved to date. One area that has not been given proper attention at the preclinical or clinical stage of drug development is the chronic medication history of the test subject. Hence, very little is known about how chronic treatment with drugs that affect multiple receptors like APDs influence the response to a potential pro-cognitive agent. Therefore, the purpose of this study was to evaluate the α7 nicotinic acetylcholine receptor (α7 nAChR) partial agonist, tropisetron in rats chronically treated with APDs with distinct pharmacological profiles. Rats were treated orally with either risperidone (2.5 mg/kg/day) or quetiapine (25.0 mg/kg/day) for 30 or 90 days and then an acute injection of vehicle or tropisetron (3.0 mg/kg) was administered before training in a novel object recognition (NOR) task. After a 48 h delay (when recollection of the familiar object was impaired in vehicle-treated animals) neither 30 nor 90 days of risperidone or quetiapine treatment improved NOR performance. In contrast, tropisetron markedly improved NOR performance in rats treated with either APD for 30 or 90 days. These animal data reinforce the argument that two commonly prescribed APDs are not pro-cognitive agents and that α7 nAChR ligands like tropisetron have potential as adjunctive treatments in schizophrenia.

Original languageEnglish (US)
Pages (from-to)180-187
Number of pages8
JournalBiochemical Pharmacology
StatePublished - May 2018


  • Antipsychotic
  • Cholinergic
  • Cognition
  • Nicotinic receptor
  • Schizophrenia

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology


Dive into the research topics of 'Tropisetron enhances recognition memory in rats chronically treated with risperidone or quetiapine'. Together they form a unique fingerprint.

Cite this